4.5 Review

Evidence for the impact of interventions and medicines reconciliation on problematic polypharmacy in the UK: A rapid review of systematic reviews

期刊

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
卷 87, 期 1, 页码 42-75

出版社

WILEY
DOI: 10.1111/bcp.14368

关键词

evidence-based medicine; health policy; overprescribing; polypharmacy; rapid review; systematic review

资金

  1. National Institute for Health Research Policy Research Programme (NIHR PRP) [PR-PRU-1217-20401]

向作者/读者索取更多资源

This rapid review of systematic reviews on problematic polypharmacy in the UK found limited evidence on the burden of PP, effectiveness of interventions, and quality of handover activities. While there is high prevalence of polypharmacy, interventions were found to reduce PP but with no significant effects on health outcomes. Activities such as medicine reconciliation were shown to reduce medication discrepancies at care transitions, but evidence quality was low. Further research is needed in the UK to better understand the prevalence and consequences of PP, effectiveness and cost-effectiveness of interventions, and barriers to implementation.
This was a rapid review of systematic reviews (SRs) on problematic polypharmacy (PP) in the UK. The commissioner-defined topics were burden of PP, interventions to reduce PP, implementation activities to increase uptake of interventions, and efficient handover between primary and secondary care to reduce PP. Databases including Medline were searched to June 2019, SR quality was assessed using AMSTAR-2 (A MeaSurement Tool to Assess systematic Reviews) and a narrative synthesis was undertaken. Except for burden of PP (SRs had to include UK studies), there were no restrictions on country, location of care or outcomes. Nine SRs were included. On burden, three SRs (including six UK studies) found a high prevalence of polypharmacy in long term care. PP was associated with mortality, although unclear if causal, with no information on costs or health consequences. On interventions, six reviews (27 UK studies) found that interventions can reduce PP, but no effects on health outcomes. On handover between primary and secondary care, one review (two UK studies) found medicine reconciliation activities to reduce medication discrepancies at care transitions reduce PP, although the evidence is low quality. No SRs on implementation activities to increase uptake of interventions were found. SR quality was variable, with some concerns regarding meta-analysis methods. Evidence of the extent of PP in the UK, and what interventions to address it are effective in the UK, is limited. Future UK research is needed on the prevalence and consequences of PP, the effectiveness and cost-effectiveness of interventions to reduce PP, and barriers and activities to ensure uptake.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据